Hi, what are you looking for?
Mexico’s headline inflation seen slowing in December, core index likely accelerated: Reuters Poll
Bostic sees Fed in cautious stance on further rate cuts amid bumpy inflation path
Euro zone inflation jumps on higher energy costs
Fitch skeptical on swift U.S. debt-ceiling resolution
US Treasury sells $38B 30Y Treasuries at slightly higher-than-expected yield
Arcturus stock soars on progress in mid-stage clinical trials
Penumbra stock rises following Stryker’s Inari Medical acquisition
Anthropic to raise $2 billion in deal valuing AI startup at $60 billion, WSJ says
US opens probe into 2.6 million Tesla vehicles over remote driving feature
US sues Cushman & Wakefield, other landlords over alleged rental price coordination
Trump’s exaggerated claim that Pennsylvania has 500,000 fracking jobs
Tucker Carlson says father Trump will give ‘spanking’ at rowdy Georgia rally
A GOP operative accused a monastery of voter fraud. Nuns fought back.
Early voting in Wisconsin slowed by label printing problems
American creating deepfakes targeting Harris works with Russian intel, documents show
Eli Manning says ‘only one team’ he’d take an ownership stake in: The New York Giants
Sierra Space CEO leaves as $5 billion company pushes to launch space plane
U.S. Steel sues Biden admin, union boss after president blocks acquisition deal
McDonald’s is the latest company to roll back diversity goals
Disney to combine its Hulu+ Live TV with streamer Fubo
Arcturus Therapeutics (NASDAQ:ARCT) shares surged 9.8% on Tuesday on dosing in two mid-stage clinical studies. Arcturus on Monday announced the initiation of dosing in...
Investing.com — Shares of Penumbra, Inc. (NYSE: NYSE:PEN) climbed 8.3% after the announcement that Stryker (NYSE: NYSE:SYK), a prominent player in the medical technology...
(Reuters) -AI startup Anthropic is in advanced talks to raise $2 billion in a deal valuing the OpenAI rival at $60 billion, the Wall...
By David Shepardson and Akash Sriram WASHINGTON (Reuters) -The National Highway Traffic Safety Administration said on Tuesday it has opened a probe into 2.6...
Investing.com– Morgan Stanley (NYSE:MS) analysts said they continued to recommend Japanese equities over China, citing increased growth concerns for the latter, especially in the...
(This Nov. 5 story has been refiled to remove a picture) By Francesco Guarascio, Khanh Vu and Ben Blanchard HANOI/TAIPEI (Reuters) – Elon Musk’s...
By Jonathan Stempel NEW YORK (Reuters) – The U.S. government sided with Argentina in urging a federal judge not to force the cash-strapped country...
Investing.com– Most Asian stocks moved in a flat-to-low range on Thursday as a rally on the back of Donald Trump winning the 2024 U.S....
By Francesco Guarascio and Phuong Nguyen HANOI (Reuters) – Vietnam faces trade volatility with a new Trump presidency, officials and supply chain experts told...
TAIPEI (Reuters) – Taiwan will help companies relocate production from China given the likely large impact on them from tariffs incoming U.S. President Donald...
By Naveen Thukral and Melanie Burton SINGAPORE (Reuters) – U.S. president-elect Donald Trump’s new administration should focus on speeding up the permitting process to...
Investing.com– U.S. stock index futures steadied in evening deals on Wednesday after Wall Street surged to record highs on Donald Trump winning the 2024...
Investing.com – Ormat (NYSE: ORA) reported third quarter EPS of $0.36, $0.02 better than the analyst estimate of $0.34. Revenue for the quarter came...
By David Shepardson, Karen Freifeld and Alexandra Alper WASHINGTON (Reuters) -GlobalFoundries and at least two other chipmakers are poised to receive their final Chips...
